» Articles » PMID: 1928969

Pulmonary Surfactant As a Vehicle for Intratracheal Delivery of Technetium Sulfur Colloid and Pentamidine in Hamster Lungs

Overview
Specialty Pulmonary Medicine
Date 1991 Oct 1
PMID 1928969
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Tracheal instillation of pentamidine in a surfactant vehicle may be an effective direct method of antibiotic delivery to the lungs. In 10 healthy hamsters, we compared the pulmonary distribution of 99mTc sulfur colloid (TcSC) mixed with pentamidine, using as a vehicle either surfactant (n = 5) or saline (n = 5). Each animal was instilled with 0.25 ml/kg of suspension containing 0.0018 mCi TcSC and pentamidine mixed with either surfactant or saline. After 4 h of spontaneous respiration, the lungs were excised, inflated to TLC, dried, and sliced into 3-mm cross sections from apex to base. Autoradiographs were examined to evaluate 99mTc distribution. The surfactant group had detectable radioactivity in 93% of all slices compared with 72% in the saline group (p = 0.02). Six slices per animal (43% of total) and their corresponding autoradiographs were analyzed for distribution of radioactivity. Lung slice area was determined by planimetry, and autoradiograph area was determined by video densitometry. We calculated the fraction of each lung slice with detectable radioactivity. The surfactant group had 41% of the lung slice areas exposed compared with 21% in the saline group (p = 0.02). The coefficient of variation of radioactive intensities within each slice was used as an index of spatial uniformity. There was a trend towards more uniform distribution in the surfactant group, with a narrower range of variation of intensities (1.51 to 2.56) than the saline group (1.95 to 6.47). We conclude that a surfactant vehicle significantly increases airspace deposition of TcSC and pentamidine instilled intratracheally in normal hamster lungs, and may improve uniformity of spread.

Citing Articles

Pulmonary surfactant impacts in vitro activity of selected antifungal drugs against Candida krusei and Candida albicans.

Nussbaumer-Proll A, Matzneller P, Eberl S, Zeitlinger M Eur J Clin Microbiol Infect Dis. 2024; 43(5):927-936.

PMID: 38483681 PMC: 11109016. DOI: 10.1007/s10096-024-04799-7.


Beyond the Interface: Improved Pulmonary Surfactant-Assisted Drug Delivery through Surface-Associated Structures.

Garcia-Mouton C, Echaide M, Serrano L, Orellana G, Salomone F, Ricci F Pharmaceutics. 2023; 15(1).

PMID: 36678885 PMC: 9866215. DOI: 10.3390/pharmaceutics15010256.


Effect of a Surfactant Additive on Drug Transport and Distribution Uniformity After Aerosol Delivery to Lungs.

Hages N, Sembrat J, Weber L, Johnston D, Stetten A, Sauleda M J Aerosol Med Pulm Drug Deliv. 2021; 35(3):146-153.

PMID: 34647795 PMC: 9242716. DOI: 10.1089/jamp.2021.0006.


Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.

Zhong Y, Li J, Liu Y, Zhao X, Male M, Song D Curr Med Sci. 2019; 39(3):493-499.

PMID: 31209823 DOI: 10.1007/s11596-019-2064-9.


Seventy-Five Years of Research on Protein Binding.

Dalhoff A Antimicrob Agents Chemother. 2017; 62(2).

PMID: 29158276 PMC: 5786787. DOI: 10.1128/AAC.01663-17.